Surgical therapy for Parkinson's disease.
暂无分享,去创建一个
[1] A. Benabid,et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation , 1995, The Lancet.
[2] Ole Isacson,et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease , 1997, Nature Medicine.
[3] R. Penn,et al. Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results. , 1990, Archives of neurology.
[4] Björn Gustavii,et al. Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease , 1997, Annals of neurology.
[5] E. Mufson,et al. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies , 1996, The Journal of comparative neurology.
[6] A. Kishore,et al. Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study. , 1999, Brain : a journal of neurology.
[7] J. Guieu,et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. , 1992, Journal of neurosurgery.
[8] B J Hoffer,et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. , 1979, Science.
[9] F. Vingerhoets,et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease , 1995, Annals of neurology.
[10] Bruce G. Jenkins,et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Narabayashi. Stereotaxic Vim thalamotomy for treatment of tremor. , 1989, European neurology.
[12] A. Björklund,et al. Immortalized neural progenitor cells for CNS gene transfer and repair , 1997, Trends in Neurosciences.
[13] C. Olanow,et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. , 1999, Archives of neurology.
[14] T. Aziz,et al. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. , 1992, British journal of neurosurgery.
[15] R. Penn,et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. , 1989, The New England journal of medicine.
[16] S. Haber,et al. FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINE , 1986, The Lancet.
[17] J. Brotchie,et al. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate , 1991, Movement disorders : official journal of the Movement Disorder Society.
[18] J. Obeso,et al. Dorsal subthalamotomy for Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[19] V Sturm,et al. Bilateral high‐frequency stimulation of the internal globus pallidus in advanced Parkinson's disease , 1998, Annals of neurology.
[20] P J Kelly,et al. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients. , 1991, Journal of neurosurgery.
[21] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[22] A. Benabid,et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus , 1991, The Lancet.
[23] A. Lang,et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease , 1998, Neurology.
[24] Surgical therapies for Parkinson's disease. A physician's perspective. , 2001, Advances in neurology.
[25] J. Bloch,et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.
[26] A. Benabid,et al. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.
[27] C. Ohye,et al. Physiological study of presumed ventralis intermedius neurons in the human thalamus. , 1979, Journal of neurosurgery.
[28] S. Dunnett,et al. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues , 2004, Experimental Brain Research.
[29] K J Burchiel,et al. DBS and diathermy interaction induces severe CNS damage , 2001, Neurology.
[30] A. Benabid,et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. , 1987, Applied neurophysiology.
[31] M. Delong,et al. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. , 1992, Journal of neurophysiology.
[32] E. Spiegel,et al. Stereotaxic Apparatus for Operations on the Human Brain. , 1947, Science.
[33] S. DeKosky,et al. Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. , 1997, Cell transplantation.
[34] J Q Trojanowski,et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.
[35] G. Percheron,et al. Long‐term thalamic stimulation in Parkinson's disease , 1994, Neurology.
[36] C. Olanow. GPi pallidotomy—have we made a dent in Parkinson's disease? , 1996, Annals of neurology.
[37] Stanley J. Wiegand,et al. Neurotrophic factors: from molecule to man , 1994, Trends in Neurosciences.
[38] A. Lang,et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. , 1997, Advances in neurology.
[39] M. Hariz,et al. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. , 1992, Stereotactic and functional neurosurgery.
[40] Richard S. J. Frackowiak,et al. Transplantation of fetal dopamine neurons in Parkinson's disease: PET {18F}6‐L‐fluorodopa studies in two patients with putaminal implants , 1992, Annals of neurology.
[41] C. Olanow,et al. Neuropathology of fetal nigral grafts in patients with Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.
[42] R. Hauser,et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[43] Jean Siegfried,et al. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. , 1994 .
[44] A. Benabid,et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.
[45] J. Lile,et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.
[46] A. Bjo¨rklund,et al. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants , 1979, Brain Research.
[47] K. Lyons,et al. High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease , 1997, Neurology.
[48] Y. Agid,et al. Deep brain stimulation in Parkinson's disease: Opposite effects of stimulation in the pallidum , 1998, Movement disorders : official journal of the Movement Disorder Society.
[49] H. Narabayashi,et al. Levodopa-induced dyskinesia and thalamotomy. , 1984, Journal of neurology, neurosurgery, and psychiatry.
[50] B Bioulac,et al. Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High‐frequency Stimulation in MPTP‐treated Monkeys , 1993, The European journal of neuroscience.
[51] P. Bossuyt,et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. , 2000, The New England journal of medicine.
[52] O. Lindvall,et al. Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen , 1987, Annals of neurology.
[53] A. Benabid,et al. Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies , 1996, The European journal of neuroscience.
[54] H. Narabayashi,et al. Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism. , 1987, Applied neurophysiology.
[55] C. Marescaux,et al. Contralateral disappearance of parkinsonian signs after subthalamic hematoma , 1992, Neurology.
[56] Y. Samson,et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. , 1994, Brain : a journal of neurology.
[57] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[58] Y Agid,et al. Transient acute depression induced by high-frequency deep-brain stimulation. , 1999, The New England journal of medicine.
[59] C. Olanow,et al. Fetal nigral transplantation as a therapy for Parkinson's disease , 1996, Trends in Neurosciences.
[60] Clive N. Svendsen,et al. New prospects for human stem-cell therapy in the nervous system , 1999, Trends in Neurosciences.
[61] B. Hoffer,et al. Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.
[62] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[63] K. Matsumoto,et al. Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy. , 1984, Journal of neurosurgery.
[64] R. Drucker-Colín,et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. , 1987, The New England journal of medicine.
[65] P. Krack,et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. , 2001, The New England journal of medicine.
[66] J. Obeso,et al. Subthalamic nucleus‐mediated excitotoxicity in parkinson's disease: A target for neuroprotection , 1998, Annals of neurology.
[67] T. Ishikawa,et al. The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[68] A. Lang,et al. High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor , 1997, Annals of neurology.
[69] Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. , 1995, Neurosurgery.
[70] Richard S. J. Frackowiak,et al. Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants , 1992, Annals of neurology.
[71] A. Benabid,et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. , 1996, Journal of neurosurgery.
[72] C. Olanow,et al. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. , 1999, The New England journal of medicine.
[73] Scott T. Grafton,et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. , 1992, The New England journal of medicine.
[74] W. Koller,et al. An algorithm (decision tree) for the management of Parkinson’s disease (2001): , 1998, Neurology.
[75] M. Hariz,et al. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. , 1992, Journal of neurosurgery.
[76] D. Jacobowitz,et al. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. , 1990, Journal of neurosurgery.
[77] C D Marsden,et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. , 1990, Science.
[78] O. Devinsky,et al. Stereotactic ventral pallidotomy for Parkinson's disease , 1995, Neurology.
[79] R. Turner,et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1‐year results of a pilot study , 1996, Annals of neurology.
[80] I. S. Cooper,et al. Chemopallidectomy and chemothalamectomy. , 1958, Journal of neurosurgery.
[81] P R Sanberg,et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. , 1995, The New England journal of medicine.
[82] Y. Samson,et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. , 1996, Brain : a journal of neurology.
[83] H. Bergman,et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. , 1994, Journal of neurophysiology.
[84] S. Leurgans,et al. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. , 2001, Archives of neurology.
[85] Vincent Frouin,et al. Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients , 1995, Annals of neurology.
[86] Y. Agid,et al. Pallidal stimulation for Parkinson's disease , 1997, Neurology.
[87] H. Jarrard. Postembryonic changes in the structure of the olfactory bulb of the chinook salmon (Oncorhynchus tshawytscha) across its life history. , 1997, Brain, behavior and evolution.
[88] I. Mitchell,et al. Regional brain uptake of 2-deoxyglucose in N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkey , 1985, Neuropharmacology.
[89] H. Bergman,et al. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.
[90] P Hawrylyshyn,et al. What happened to VIM thalamotomy for Parkinson's disease? , 1983, Applied neurophysiology.
[91] T. Ōkuma,et al. Procaine oil blocking of the globus pallidus. , 1956, A.M.A. archives of neurology and psychiatry.
[92] J. Obeso,et al. Pathophysiology of the basal ganglia in Parkinson's disease , 2000, Trends in Neurosciences.
[93] D. Spencer,et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. , 1992, The New England journal of medicine.
[94] F. J. Gillingham,et al. The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study. , 1980, Journal of neurosurgery.
[95] A. Lang,et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. , 2000, The New England journal of medicine.